Core Insights - ORDER AI LLC has launched MENU ORDER AI, the first app designed for users of GLP-1 medications, enabling them to make informed menu choices while dining out or ordering in [2][5] - The app utilizes advanced AI technology to identify high-protein, GLP-1-friendly meal options from any restaurant menu, enhancing the dining experience for users [4][5] - The adoption of GLP-1 medications is significantly changing consumer behavior, with approximately 6% of U.S. adults currently using these medications, a figure expected to double by 2027 [5][6] Company Overview - ORDER AI LLC is a woman-owned health-tech company that aims to bridge the gap between AI, nutrition, and dining, providing a unique perspective in a predominantly male industry [2][3] - The founder, Melissa Butler, emphasizes that the app acts like a personal nutritionist, guiding users in real-time to make healthier dining choices [4][6] Industry Impact - The rise of GLP-1 medication usage is reshaping the food market, leading to smaller portion sizes and reduced spending in restaurants as users adapt their eating habits [5][6] - A Forbes analysis highlights the broader economic implications of GLP-1 adoption, affecting various industries from private equity to retail [6] App Functionality - MENU ORDER AI allows users to scan or photograph menus, providing instant recommendations for meals that align with their dietary goals, focusing on high-protein and low-carbohydrate options [4][5] - The app supports users in maintaining portion control and consistent dietary progress while dining out [4][5] Availability - MENU ORDER AI is now available for download on the Apple App Store, marking a significant step in the intersection of technology and health [7][8]